Madrigal Pharmaceuticals Inc
NASDAQ:MDGL
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Madrigal Pharmaceuticals Inc
NASDAQ:MDGL
|
US |
|
Sunstone Hotel Investors Inc
NYSE:SHO
|
US |
|
B
|
Bangkok Life Assurance PCL
SET:BLA
|
TH |
|
D
|
Dunelm Group PLC
OTC:DNLMY
|
UK |
|
H
|
Halliburton Co
XETRA:HAL
|
US |
|
S
|
Salesforce Inc
XETRA:FOO
|
US |
|
F
|
Fomento de Construcciones y Contratas SA
DUS:FCC
|
ES |
|
P
|
Procter & Gamble Co
DUS:PRG
|
US |
|
Silvercorp Metals Inc
TSX:SVM
|
CA |
|
Infosys Ltd
F:IOY
|
IN |
|
S
|
Silvercorp Metals Inc
XMUN:S9Y
|
CA |
|
S
|
Subsea 7 SA
XBER:SOC
|
UK |
Wall St Price Targets
MDGL Price Targets Summary
Madrigal Pharmaceuticals Inc
According to Wall Street analysts, the average 1-year price target for MDGL is 692.38 USD with a low forecast of 547.42 USD and a high forecast of 1 012.2 USD.
Price Targets
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is MDGL's stock price target?
Price Target
692.38
USD
According to Wall Street analysts, the average 1-year price target for MDGL is 692.38 USD with a low forecast of 547.42 USD and a high forecast of 1 012.2 USD.
What is the Revenue forecast for Madrigal Pharmaceuticals Inc?
Projected CAGR
48%
Over the last 13 years, the compound annual growth rate for Revenue has been 102%. The projected CAGR for the next 3 years is 48%.
What is the Gross Profit forecast for Madrigal Pharmaceuticals Inc?
Projected CAGR
45%
The compound annual growth rate for Gross Profit over the next 3 years is 45%.
